These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17640669)

  • 1. RB activity alters checkpoint response and chemosensitivity in lung cancer lines.
    Reed MF; Zagorski WA; Knudsen ES
    J Surg Res; 2007 Oct; 142(2):364-72. PubMed ID: 17640669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoblastoma deficiency increases chemosensitivity in lung cancer.
    Zagorski WA; Knudsen ES; Reed MF
    Cancer Res; 2007 Sep; 67(17):8264-73. PubMed ID: 17804741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma.
    Mack PC; Gandara DR; Bowen C; Edelman MJ; Paglieroni T; Schnier JB; Gelmann EP; Gumerlock PH
    Clin Cancer Res; 1999 Sep; 5(9):2596-604. PubMed ID: 10499638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G1 arrest induction represents a critical determinant for cisplatin cytotoxicity in G1 checkpoint-retaining human cancers.
    Un F
    Anticancer Drugs; 2007 Apr; 18(4):411-7. PubMed ID: 17351393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel.
    Grim J; D'Amico A; Frizelle S; Zhou J; Kratzke RA; Curiel DT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2415-23. PubMed ID: 9815642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RB protein status and chemosensitivity in non-small cell lung cancers.
    Yamamoto Y; Shimizu E; Masuda N; Takada M; Sone S
    Oncol Rep; 1998; 5(2):447-51. PubMed ID: 9468577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
    Reed MF; Zagorski WA; Howington JA; Zilfou JT; Knudsen ES
    Ann Thorac Surg; 2006 Jul; 82(1):249-53. PubMed ID: 16798224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1α,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrest.
    Washington MN; Kim JS; Weigel NL
    Prostate; 2011 Jan; 71(1):98-110. PubMed ID: 20632309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents.
    Mayhew CN; Perkin LM; Zhang X; Sage J; Jacks T; Knudsen ES
    Oncogene; 2004 May; 23(23):4107-20. PubMed ID: 15064736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers.
    Marot D; Opolon P; Brailly-Tabard S; Elie N; Randrianarison V; Connault E; Foray N; Feunteun J; Perricaudet M
    Gene Ther; 2006 Feb; 13(3):235-44. PubMed ID: 16208422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpoint.
    Kim JS; Pirnia F; Choi YH; Nguyen PM; Knepper B; Tsokos M; Schulte TW; Birrer MJ; Blagosklonny MV; Schaefer O; Mushinski JF; Trepel JB
    Oncogene; 2000 Dec; 19(52):6082-90. PubMed ID: 11146561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
    Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ
    Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
    Srethapakdi M; Liu F; Tavorath R; Rosen N
    Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of retinoblastoma tumor suppressor gene expression on chemosensitivity of human osteosarcoma cell lines.
    Iida K; Nobori T; Matsumine A; Isaka A; Seto M; Shiraishi T; Uchida A
    Oncol Rep; 2003; 10(6):1961-5. PubMed ID: 14534726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung Cancer.
    Thangavel C; Boopathi E; Liu Y; McNair C; Haber A; Perepelyuk M; Bhardwaj A; Addya S; Ertel A; Shoyele S; Birbe R; Salvino JM; Dicker AP; Knudsen KE; Den RB
    Clin Cancer Res; 2018 Mar; 24(6):1402-1414. PubMed ID: 29311118
    [No Abstract]   [Full Text] [Related]  

  • 16. Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
    Sharma A; Comstock CE; Knudsen ES; Cao KH; Hess-Wilson JK; Morey LM; Barrera J; Knudsen KE
    Cancer Res; 2007 Jul; 67(13):6192-203. PubMed ID: 17616676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylacetate inhibits growth and modulates cell cycle gene expression in renal cancer cell lines.
    Franco OE; Onishi T; Umeda Y; Soga N; Wakita T; Arima K; Yanagawa M; Sugimura Y
    Anticancer Res; 2003; 23(2B):1637-42. PubMed ID: 12820434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells.
    Kataoka M; Wiehle S; Spitz F; Schumacher G; Roth JA; Cristiano RJ
    Oncogene; 2000 Mar; 19(12):1589-95. PubMed ID: 10734319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
    McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
    Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.